Omada Health, Inc.
OMDA
$12.61
$0.040.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.49% | 10.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.49% | 10.85% | |||
| Cost of Revenue | -3.38% | 8.99% | |||
| Gross Profit | 19.06% | 11.82% | |||
| SG&A Expenses | 4.15% | 7.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.87% | 7.35% | |||
| Operating Income | 230.56% | 42.15% | |||
| Income Before Tax | 262.33% | 40.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 262.33% | 40.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 262.33% | 40.16% | |||
| EBIT | 230.56% | 42.15% | |||
| EBITDA | 509.71% | 61.43% | |||
| EPS Basic | 261.34% | 77.20% | |||
| Normalized Basic EPS | 578.45% | 92.32% | |||
| EPS Diluted | 246.46% | 77.20% | |||
| Normalized Diluted EPS | 534.48% | 92.32% | |||
| Average Basic Shares Outstanding | 0.69% | 162.43% | |||
| Average Diluted Shares Outstanding | 10.88% | 162.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||